Cowealth Medical Holding Co., Ltd. (TPEX:4745)
Taiwan · Delayed Price · Currency is TWD 10.40
-0.40 (-3.70%)
Jul 30, 2026, 1:30 PM CST
Cowealth Medical Holding Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,864 | 2,956 | 4,193 | 4,813 | 5,626 | 5,140 |
Revenue Growth | -27.32% | -29.49% | -12.88% | -14.46% | 9.47% | 8.85% |
Gross Profit Gross Profit Growth | 382.31 | 392.18 | 791.52 | 984.45 | 1,104 | 1,058 |
Operating Income Operating Income Growth | -278.11 | -275.42 | 97.13 | 264.17 | 369.83 | 339.84 |
Net Income Net Income Growth | -247.25 | -246.56 | 0.63 | 49.11 | 94.12 | 139.46 |
Earnings Per Share EPS Growth | -3.19 | -3.18 | 0.01 | 0.63 | 1.21 | 1.80 |
EPS Growth | - | - | -98.71% | -47.93% | -32.78% | 12.07% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Reagents and Other Reagents and Other Growth | 2,991 | 3,084 | 4,350 | 5,021 | 4,439 | 4,651 |
Adjustments and Eliminations Adjustments and Eliminations Growth | -282.27 | -257.08 | -302.59 | -862.84 | -265.32 | - |
Equipment Equipment Growth | 155.13 | 129.26 | 145.08 | 654.51 | 1,452 | 488.83 |
Total Total Growth | 2,864 | 2,956 | 4,193 | 4,813 | 5,626 | 5,140 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 948.18 | 1,136 | 1,233 | 927.28 | 1,427 | 842.68 |
Total Debt Total Debt Growth | 757.27 | 519.71 | 514.67 | 647.24 | 692.69 | 913.34 |
Net Cash (Debt) Net Cash Growth | 190.91 | 616.42 | 718.3 | 280.04 | 734.8 | -70.65 |
Net Cash Growth | -70.20% | -14.18% | 156.50% | -61.89% | - | - |
Net Cash Per Share Net Cash Per Share Growth | 2.46 | 7.96 | 9.27 | 3.61 | 9.48 | -0.91 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -401.62 | 15.53 | 469.43 | 45.02 | -267.59 | -118.38 |
Capital Expenditures CapEx Growth | -7.41 | -9.07 | -57.45 | -206.37 | -18.68 | -34.54 |
Free Cash Flow Free Cash Flow Growth | -409.03 | 6.46 | 411.98 | -161.34 | -286.27 | -152.91 |
Free Cash Flow Growth | - | -98.43% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 13.35% | 13.27% | 18.88% | 20.46% | 19.63% | 20.58% |
Operating Margin | -9.71% | -9.32% | 2.32% | 5.49% | 6.57% | 6.61% |
Pretax Margin | -10.09% | -9.65% | 2.12% | 5.37% | 6.90% | 6.51% |
Profit Margin | -8.63% | -8.34% | 0.01% | 1.02% | 1.67% | 2.71% |
FCF Margin | -14.28% | 0.22% | 9.83% | -3.35% | -5.09% | -2.97% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.400 | 1.600 | 1.500 |
Dividend Per Share Growth | -75.00% | 6.67% | 25.00% |
Dividend Yield | 1.58% | 6.93% | 6.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 2518.03 | 40.69 | 20.45 | 14.77 |
Forward PE | - | 14.84 | 14.84 | 14.84 | 14.84 | 9.01 |
P/FCF Ratio | - | 303.74 | 3.85 | - | - | - |
PS Ratio | 0.29 | 0.66 | 0.38 | 0.42 | 0.34 | 0.40 |